Skip to content

Auriculotherapy in the treatment of Anxiety in people with HIV

Auriculotherapy in the management of Anxiety symptoms in people living with HIV: randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2jwy9xf
Enrollment
Unknown
Registered
2021-10-15
Start date
2021-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

Experimental group: 77 people living with HIV with scores from 35 on the anxiety scale will be submitted to auricular acupressure technique using mustard seeds in the points: Shen Men, Kidney, Sympath
in alternate ears, starting with the dominant ear
with a stay of 3 days
in sessions twice a week for 8 weeks. Control group: 77 people living with HIV with scores from 35 on the anxiety scale will undergo a placebo auricular acupressure technique using mustard in the poin
2.right foot joint
3. left hand joint
4. left foot joint
5. shoulder joint
in sessions twice a week for 8 weeks.
E02.190.204

Sponsors

Federal University of Ceara
Lead Sponsor
Federal University of Ceara
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: People living with HIV; 18 years of age or older; and with a score greater than or equal to 35 on the State-Trait Anxiety Inventory.

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

MeasureTime frame
Improvement in anxiety, observed through the difference in their mean scores, measured through the State-Trait Anxiety Inventory, between the baseline, the end of the intervention and one month after the end of the treatment.

Secondary

MeasureTime frame
Stress Reduction, verified through the difference in the average scores on the Perceived Stress Scale. Data collected at baseline, at the end of the intervention, and one month after completion of treatment. ;Improvement in Depression, verified through the difference in the average scores on the Beck Depression Inventory. Data collected at baseline, at the end of the intervention and one month after completion of treatment.

Countries

Brazil

Contacts

Public ContactOdaleia Farias
odaleia@alu.ufc.br+558533668455

Outcome results

None listed

Source: REBEC (via WHO ICTRP)